Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

This study is currently recruiting participants.

Study NCT00217438 Information provided by Fred Hutchinson Cancer Research Center

First Received: September 20, 2005 Last Updated: December 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2015 (Final data collection date for primary outcome measure)